Vical Announces News Release and Conference Call Schedule for Second Quarter 2014 Financial Results
July 24, 2014 06:30 ET
|
Vical Incorporated
SAN DIEGO, July 24, 2014 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that the company will report financial results for the three and six months ended June 30, 2014, before...
Vical to Present at the JMP Securities Annual Healthcare Conference
June 18, 2014 06:30 ET
|
Vical Incorporated
SAN DIEGO, June 18, 2014 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that the company will provide an overview of its technologies, development programs, and outlook on...
Vical Reports First Quarter 2014 Financial Results and Progress in Key Development Programs
May 01, 2014 06:30 ET
|
Vical Incorporated
SAN DIEGO, May 1, 2014 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today reported financial results for the quarter ended March 31, 2014. The net loss for the first quarter of 2014 was $3.5...
Vical Announces News Release and Conference Call Schedule for First Quarter 2014 Financial Results
April 23, 2014 06:30 ET
|
Vical Incorporated
SAN DIEGO, April 23, 2014 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that the company will report financial results for the three months ended March 31, 2014, before the...
Vical to Present at the ROTH Capital Partners 26th Annual Growth Stock Conference
March 05, 2014 16:05 ET
|
Vical Incorporated
SAN DIEGO, March 5, 2014 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that the company will provide an overview of its technologies, development programs, and outlook on...
Vical to Present at the 34th Annual Cowen Health Care Conference
February 26, 2014 16:05 ET
|
Vical Incorporated
SAN DIEGO, Feb. 26, 2014 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that the company will provide an overview of its technologies, development programs, and outlook on...
Vical Reports 2013 Financial Results and Progress in Key Development Programs
February 12, 2014 06:30 ET
|
Vical Incorporated
SAN DIEGO, Feb. 12, 2014 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today reported financial results for the year ended December 31, 2013. The net loss for 2013 was $31.2 million, or $0.36...
Vical to Present at the 2014 Leerink Global Healthcare Conference
February 07, 2014 06:30 ET
|
Vical Incorporated
SAN DIEGO, Feb. 7, 2014 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that the company will provide an overview of its technologies, development programs, and outlook on...
Vical Announces News Release and Conference Call Schedule for 2013 Financial Results
February 05, 2014 06:30 ET
|
Vical Incorporated
SAN DIEGO, Feb. 5, 2014 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that the company will report financial results for the three months and twelve months ended December 31,...
Vical Announces Initiation of Phase 1/2 Trial of a Therapeutic HSV-2 Vaccine for Genital Herpes
December 17, 2013 07:00 ET
|
Vical Incorporated
SAN DIEGO, Dec. 17, 2013 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced the initiation of its Phase 1/2 trial of the company's Vaxfectin™-formulated therapeutic vaccine for...